electroCore, Inc. (ECOR)
ECOR Stock Price Chart
Explore electroCore, Inc. interactive price chart. Choose custom timeframes to analyze ECOR price movements and trends.
ECOR Company Profile
Discover essential business fundamentals and corporate details for electroCore, Inc. (ECOR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 Jun 2018
Employees
73.00
Website
https://www.electrocore.comCEO
Thomas J. Errico
Description
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
ECOR Financial Timeline
Browse a chronological timeline of electroCore, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.41, while revenue estimate is $9.49m.
Earnings released on 6 May 2026
EPS came in at -$0.59 matching the estimated -$0.59, while revenue for the quarter reached $9.58m , beating expectations by +6.35%.
Earnings released on 19 Mar 2026
EPS came in at -$0.34 surpassing the estimated -$0.35 by +2.86%, while revenue for the quarter reached $9.24m , beating expectations by +1.53%.
Earnings released on 5 Nov 2025
EPS came in at -$0.40 falling short of the estimated -$0.36 by -11.11%, while revenue for the quarter reached $8.69m , beating expectations by +9.77%.
Earnings released on 6 Aug 2025
EPS came in at -$0.35 falling short of the estimated -$0.32 by -9.37%, while revenue for the quarter reached $7.38m , missing expectations by -5.91%.
Earnings released on 7 May 2025
EPS came in at -$0.47 surpassing the estimated -$0.56 by +16.07%, while revenue for the quarter reached $6.72m , missing expectations by -3.03%.
Earnings released on 12 Mar 2025
EPS came in at -$0.40 falling short of the estimated -$0.34 by -17.65%, while revenue for the quarter reached $7.05m , missing expectations by -0.13%.
Earnings released on 13 Nov 2024
EPS came in at -$0.31 falling short of the estimated -$0.29 by -6.90%, while revenue for the quarter reached $6.55m , beating expectations by +0.99%.
Earnings released on 7 Aug 2024
EPS came in at -$0.38 surpassing the estimated -$0.39 by +2.56%, while revenue for the quarter reached $6.14m , beating expectations by +10.41%.
Earnings released on 8 May 2024
EPS came in at -$0.53 falling short of the estimated -$0.50 by -6.00%, while revenue for the quarter reached $5.44m , beating expectations by +14.11%.
Earnings released on 13 Mar 2024
EPS came in at -$0.61 falling short of the estimated -$0.55 by -10.91%, while revenue for the quarter reached $5.19m , beating expectations by +4.45%.
Earnings released on 8 Nov 2023
EPS came in at -$0.68 falling short of the estimated -$0.64 by -6.25%, while revenue for the quarter reached $4.51m , beating expectations by +1.30%.
Earnings released on 9 Aug 2023
EPS came in at -$1.03 falling short of the estimated -$1.00 by -3.00%, while revenue for the quarter reached $3.55m , beating expectations by +3.23%.
Earnings released on 3 May 2023
EPS came in at -$1.24 falling short of the estimated -$1.00 by -24.00%, while revenue for the quarter reached $2.78m , missing expectations by -5.76%.
Earnings released on 8 Mar 2023
EPS came in at -$1.22 falling short of the estimated -$1.11 by -9.91%, while revenue for the quarter reached $2.56m , beating expectations by +8.47%.
Stock split effective on 15 Feb 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 3 Nov 2022
EPS came in at -$1.20 falling short of the estimated -$1.05 by -14.29%, while revenue for the quarter reached $1.98m , missing expectations by -12.61%.
Earnings released on 4 Aug 2022
EPS came in at -$1.20 matching the estimated -$1.20, while revenue for the quarter reached $2.16m , beating expectations by +6.92%.
Earnings released on 5 May 2022
EPS came in at -$1.20 falling short of the estimated -$0.75 by -60.00%, while revenue for the quarter reached $1.90m , beating expectations by +7.06%.
Earnings released on 10 Mar 2022
EPS came in at -$1.05 matching the estimated -$1.05, while revenue for the quarter reached $1.49m , missing expectations by -0.71%.
Earnings released on 4 Nov 2021
EPS came in at -$0.90 surpassing the estimated -$1.20 by +25.00%, while revenue for the quarter reached $1.49m , missing expectations by -4.67%.
Earnings released on 5 Aug 2021
EPS came in at -$1.35 surpassing the estimated -$1.65 by +18.18%, while revenue for the quarter reached $1.27m , missing expectations by -0.04%.
ECOR Stock Performance
Access detailed ECOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
